Related Experiment Video

Updated: Jun 8, 2026

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Effect of mycophenolate mofetil on cerulein-induced acute pancreatitis

B Tasdogan1, H F Kucuk, N Kurt

  • 1Kartal Research and Education Hospital, Istanbul, Turkey.

European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes
|October 7, 2010
PubMed
Abstract

Insights

Mycophenolate mofetil (MMF) demonstrated beneficial effects in an experimental rat model of acute pancreatitis. This immunosuppressant agent improved both biochemical markers and histopathological findings associated with the condition.

Area of Science:

  • Gastroenterology
  • Immunopharmacology
  • Experimental Pathology

Background:

  • Acute pancreatitis is a serious inflammatory condition of the pancreas.
  • Current treatments for acute pancreatitis are limited, necessitating research into novel therapeutic agents.
  • Mycophenolate mofetil (MMF) is an immunosuppressant with potential anti-inflammatory properties.

Purpose of the Study:

  • To investigate the therapeutic effects of mycophenolate mofetil (MMF) on acute pancreatitis.
  • To evaluate the impact of MMF on key biochemical and histopathological indicators of pancreatitis in an animal model.

Main Methods:

  • Acute pancreatitis was induced in rats using cerulein administration.
  • Three groups of rats were studied: control (saline), MMF low dose (14 mg/kg), and MMF high dose.
  • Biochemical markers (amylase, AST, bilirubin) and pancreatic histopathology (edema, necrosis, inflammation) were assessed.

Main Results:

  • Significant differences in amylase, serum AST, edema, and inflammatory infiltration were observed between groups (p < 0.002).
  • The control group exhibited the highest levels of amylase, serum AST, and edema.
  • The highest MMF dose group showed the lowest levels of pancreatic edema.

Conclusions:

  • Mycophenolate mofetil (MMF) demonstrated a protective effect in a rat model of cerulein-induced acute pancreatitis.
  • MMF treatment led to improvements in biochemical parameters and reduced histopathological damage.
  • These findings suggest MMF as a potential therapeutic agent for acute pancreatitis.

More Related Videos

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Related Concept Videos

Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Acute Pancreatitis I: Introduction01:25

Acute Pancreatitis I: Introduction

Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...